Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Upgrades Cemex to Overweight, Maintains Price Target to $9

Author: Benzinga Newsdesk | July 31, 2024 07:25am
Barclays analyst Benjamin Theurer upgrades Cemex (NYSE:CX) from Equal-Weight to Overweight and maintains the price target from $9 to $9.

Posted In: CX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist